By merging computational systems modeling and experimental approaches, we have uncovered treatments reprogramming pro-angiogenic monocytes present in breast tumor into immunologically potent cells capable of mediating an anti-tumor immune response. The unraveled pathways and ligands which underlie monocyte pro-angiogenic activity have a strong predictive value for breast cancer patient relapse - free survival
Metastasis is the leading cause of cancer-related deaths. Recent developments in cancer immunotherap...
Breast cancer is one of the most common and malignant cancers nowadays. Like many cancers, it is ex...
Breast cancer is one of the most common and malignant cancers nowadays. Like many cancers, it is ex...
By merging computational systems modeling and experimental approaches, we have uncovered treatments ...
Angiogenesis plays a key role in tumor growth and cancer progression. TIE-2-expressing monocytes (TE...
Angiogenesis plays a key role in tumor growth and cancer progression. TIE-2-expressing monocytes (TE...
Angiogenesis plays a key role in tumor growth and cancer progression. TIE-2-expressing monocytes (TE...
<div><p>Angiogenesis plays a key role in tumor growth and cancer progression. TIE-2-expressing monoc...
Angiogenesis plays a key role in tumor growth and cancer progression. TIE-2-expressing monocytes (TE...
In experimental mouse models of cancer, increasingly compelling evidence point toward a contribution...
In experimental mouse models of cancer, increasingly compelling evidence point toward a contribution...
PURPOSE: Tumor-associated TIE-2-expressing monocytes (TEM) are highly proangiogenic cells critical f...
A mathematical model integrating tumor angiogenesis and tumor-targeted cytotoxicity by immune cells ...
A mathematical model integrating tumor angiogenesis and tumor-targeted cytotoxicity by immune cells ...
PURPOSE: Tumor-associated TIE-2-expressing monocytes (TEM) are highly proangiogenic cells critical f...
Metastasis is the leading cause of cancer-related deaths. Recent developments in cancer immunotherap...
Breast cancer is one of the most common and malignant cancers nowadays. Like many cancers, it is ex...
Breast cancer is one of the most common and malignant cancers nowadays. Like many cancers, it is ex...
By merging computational systems modeling and experimental approaches, we have uncovered treatments ...
Angiogenesis plays a key role in tumor growth and cancer progression. TIE-2-expressing monocytes (TE...
Angiogenesis plays a key role in tumor growth and cancer progression. TIE-2-expressing monocytes (TE...
Angiogenesis plays a key role in tumor growth and cancer progression. TIE-2-expressing monocytes (TE...
<div><p>Angiogenesis plays a key role in tumor growth and cancer progression. TIE-2-expressing monoc...
Angiogenesis plays a key role in tumor growth and cancer progression. TIE-2-expressing monocytes (TE...
In experimental mouse models of cancer, increasingly compelling evidence point toward a contribution...
In experimental mouse models of cancer, increasingly compelling evidence point toward a contribution...
PURPOSE: Tumor-associated TIE-2-expressing monocytes (TEM) are highly proangiogenic cells critical f...
A mathematical model integrating tumor angiogenesis and tumor-targeted cytotoxicity by immune cells ...
A mathematical model integrating tumor angiogenesis and tumor-targeted cytotoxicity by immune cells ...
PURPOSE: Tumor-associated TIE-2-expressing monocytes (TEM) are highly proangiogenic cells critical f...
Metastasis is the leading cause of cancer-related deaths. Recent developments in cancer immunotherap...
Breast cancer is one of the most common and malignant cancers nowadays. Like many cancers, it is ex...
Breast cancer is one of the most common and malignant cancers nowadays. Like many cancers, it is ex...
DOI
Add to ORKG